» Articles » PMID: 17549248

Gene Therapy for Severe Combined Immunodeficiency: Are We There Yet?

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2007 Jun 6
PMID 17549248
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Inherited and acquired diseases of the hematopoietic system can be cured by allogeneic hematopoietic stem cell transplantation. This treatment strategy is highly successful when an HLA-matched sibling donor is available, but if not, few therapeutic options exist. Gene-modified, autologous bone marrow transplantation can circumvent the severe immunological complications that occur when a related HLA-mismatched donor is used and thus represents an attractive alternative. In this review, we summarize the advantages and limitations associated with the use of gene therapy to cure SCID. Insertional mutagenesis and technological improvements aimed at increasing the safety of this strategy are also discussed.

Citing Articles

Translation of unspliced retroviral genomic RNA in the host cell is regulated in both space and time.

Leon-Diaz F, Chamontin C, Laine S, Socol M, Bertrand E, Mougel M J Cell Biol. 2025; 224(4).

PMID: 39868815 PMC: 11775842. DOI: 10.1083/jcb.202405075.


Differentiation ability of hematopoietic stem cells and mesenchymal stem cells isolated from human peripheral blood.

Samundeshwari E, Kattaru S, Kodavala S, Chandrasekhar C, Sarma P Front Cell Dev Biol. 2025; 12:1450543.

PMID: 39744010 PMC: 11688275. DOI: 10.3389/fcell.2024.1450543.


A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases.

Fischell J, Fishman P Front Neurosci. 2021; 15:747726.

PMID: 34630029 PMC: 8497810. DOI: 10.3389/fnins.2021.747726.


Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID.

Garcia-Perez L, van Eggermond M, van Roon L, Vloemans S, Cordes M, Schambach A Mol Ther Methods Clin Dev. 2020; 17:666-682.

PMID: 32322605 PMC: 7163047. DOI: 10.1016/j.omtm.2020.03.016.


Darwinian selection within an individual or somatic selection: facts and models.

Veitia R J Mol Cell Biol. 2019; 11(8):719-722.

PMID: 30806666 PMC: 6788724. DOI: 10.1093/jmcb/mjz014.


References
1.
Dadi H, Simon A, Roifman C . Effect of CD3delta deficiency on maturation of alpha/beta and gamma/delta T-cell lineages in severe combined immunodeficiency. N Engl J Med. 2003; 349(19):1821-8. DOI: 10.1056/NEJMoa031178. View

2.
Fischer A . Human primary immunodeficiency diseases: a perspective. Nat Immunol. 2003; 5(1):23-30. DOI: 10.1038/ni1023. View

3.
Konno A, Wada T, Schurman S, Garabedian E, Kirby M, Anderson S . Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages. Blood. 2003; 103(2):676-8. DOI: 10.1182/blood-2003-05-1739. View

4.
Kahl C, Marsh J, Fyffe J, Sanders D, Cornetta K . Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus. J Virol. 2004; 78(3):1421-30. PMC: 321387. DOI: 10.1128/jvi.78.3.1421-1430.2004. View

5.
Dave U, Jenkins N, Copeland N . Gene therapy insertional mutagenesis insights. Science. 2004; 303(5656):333. DOI: 10.1126/science.1091667. View